Nevro (NVRO) Misses Q2 EPS by 10c, Sales Beat
Get Alerts NVRO Hot Sheet
Join SI Premium – FREE
Nevro (NYSE: NVRO) reported Q2 EPS of ($0.40), $0.10 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $78 million versus the consensus estimate of $74.96 million.
Nevro reiterates its expectations for worldwide revenue for 2017 to be in the range of $310 to $320 million.
For earnings history and earnings-related data on Nevro (NVRO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sotera Health Co. (SHC) Tops Q3 EPS by 2c; Offers Guidance
- Sotera Health Co. (SHC) Tops Q3 EPS by 2c
- Upstart Holdings (UPST) Tops Q3 EPS by 12c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share